Abstract: Feasibility and effect of midazolam administration on blood analytes and for sedation of Passeriformes being collected in a larger study of genetic biodiversity was assessed. Midazolam (5.6±2.7 mg/kg) was administered intranasally prior to sampling, euthanasia, and specimen preparation of 104 passerine birds. Each bird was assessed for sedation score and then multiple analytes were determined from jugular blood samples using the i-STAT ® point of care analyzer at "bird side". Most birds were acceptably sedated, sedation became more pronounced as midazolam dose increased, and only a single bird died. Electrolyte concentrations and venous blood gas analytes were affected by midazolam administration while blood pH, packed cell volume, hemoglobin, and calculated hematocrit were not. Intranasal midazolam gives adequate sedation and is safe for short-term use in free-living Passeriformes. Based on venous blood analyte data, sedation of Passeriformes prior to handling appears to reduce stress but also produces venous blood gas differences consistent with hypoventilation relative to birds which were not given midazolam. Further study is recommended to investigate midazolam's continued use in freeliving avian species. Studies should include safety, reversal and recovery, effect upon additional endogenous analytes, and compatibility with studies of ecology and toxicology associated with pollution or other environmental degradation in Passeriformes.
Introduction
Sampling for evaluation of hematological and biochemical analytes is a useful, nonlethal, and minimally invasive method to determine health status of the individual bird and avian populations. [1] [2] [3] [4] [5] [6] [7] [8] However, venipuncture and blood sample collection from Passeriformes is often hindered by patient size and temperament as well as clinical skill of the sample collector. Furthermore, the effect of capture and handling stress on various blood analytes is difficult to control and account for in field studies. 9 Midazolam is a short-acting benzodiazepine with potent anxiolytic, amnestic, hypnotic, anticonvulsant, muscle relaxant, and sedative properties, convenient for use in animals based on a short elimination half-life, water solubility allowing multiple administration options, rapid onset of action, reversibility, and minimal cardiovascular effects. [10] [11] [12] Midazolam has been administered intranasally to sedate parrots, canaries Serinus canarius, finches Taeniopygia guttata, and other avian species for research and clinical case management. [11] [12] [13] [14] [15] [16] Sedation with midazolam in birds decreases vocalization, flight, and defense responses, and facilitates handling for diagnostic and minor therapeutic procedures. 11, 12, 17, 18 Additional study of midazolam has been recommended for "reducing stress in captured wild birds". The objective of this prospective cross-sectional study was to assess feasibility and safety of the sedative midazolam administered intranasally to Passeriformes in a field setting. Midazolam was hypothesized to be an easily administered, rapid-onset, effective, and safe sedative for Passeriformes to facilitate handling and sample collection. Midazolam's effect on select venous blood analytes was also assessed by comparing those obtained in this study to a study that assessed Passeriforme health in nonsedated birds. 19 Some nonspecific measures of stress such as lactate or glucose concentrations were also hypothesized to differ based on administration of midazolam. These findings are the first large-scale assessment of midazolam sedation in free-living Passeriformes and the first report of the effect of midazolam on venous blood analytes in these species.
Materials and methods specimen collection
In conjunction with an ongoing specimen collection for assessment of avian genetic variation and biodiversity in 
animal sampling
Birds were captured via mist net and placed in cloth bags until administration of midazolam (5 mg/mL injection USP; Hospira, Inc., Lake Forest, IL, USA) intranasally at a dose of 5.55±2.66 (mean ± standard deviation [SD], range 2.39-13.5) mg/kg. 12, 15, 17 Birds were initially dosed based on weights (Table 1) generalized from known species weight ranges; exact dosages were later recalculated using postmortem frozen bird weight. Birds were then held in bags for at least 5 minutes to allow calming and sedation to occur before sampling. Sedation score was determined based on a modified sedation scale (Table 2) . 20, 21 Animals were manually restrained for collection of 0.2-0.5 mL of blood via jugular venipuncture with needle and syringe. Jugular venipuncture was chosen as a central nonlethal sampling option which 
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Midazolam sedates Passeriformes system are measured directly, but TCO 2 , BE, Hgb and sO 2 , are calculated. 24 Lithium heparin microhematocrit tubes (Statspin ® centrifuge; Iris ® sample processing, Westwood, MA, USA) were used to determine packed cell volume (PCV) and were centrifuged at 15,000 g for 3 minutes within 24 hours of blood collection. After venipuncture, a physical examination was performed. Birds were then humanely killed via thoracic compression and frozen until preparation as standard museum specimens that are deposited at the Biodiversity Research and Teaching Collections at Texas A&M University. Species, sex, and age were determined based on external field markings and confirmed during specimen preparation. Body weight was determined at specimen preparation.
additional calculations
Temperature corrections with an assumed Passeriforme core body temperature of 41.3°C were performed for pH, pCO 2 , and pO 2 as follows: 19 Species were grouped for comparison of values via Kruskal-Wallis one-way analysis of variance when species numbers were greater than two and had at least one bird in the sedated and nonsedated categories (Table 3 ). Analysis of variance was used to assess the effect of midazolam dose (mg/kg) on bird sedation score. Kruskal-Wallis one-way analysis of variance assessed the effect of Hct on BUN. A Bland-Altman plot 26 The effect of selected variables on iSTAT-1 values was assessed using a linear mixed model with iSTAT-1 values as outcome variables; age, sex, midazolam sedation (1 or 0), and interactions as fixed effects; and species as random effect. Residual plots were used to assess linearity, homogeneity of variances, normality, and outliers. A type III analysis of variance was performed on the fixed effects and post hoc comparisons were performed using a Tukey adjustment. When necessary to meet assumptions of the linear mixed models, log transformation of the outcome variables was used. When assumptions of the linear models could not be met, a two-sample Wilcoxon test was performed on the iSTAT-1 values to assess the effect of midazolam sedation, sex, and age separately. Alpha of 0.05 was used for significance for all statistical outcomes.
Results
One hundred and four birds were captured and sedated from a variety of Passeriformes, mostly of the Paridae family (Table 3) . Midazolam doses administered averaged 5.6±2.7 mg/kg. Notable side effects were regurgitation in two birds and egg production in three birds after administration of midazolam; these clinical signs were not noted in the previous field season. A single bird, excluded from the figure, received 2.79 mg/kg midazolam and was given a sedation score of 2 but died during sampling. Sedation scores increased as midazolam dose increased ( Figure 1) . To assess the effect of midazolam on multiple blood analytes, we compared analytes of blood samples from 95 Passeriformes which had midazolam administered to those obtained from 96 birds which were not administered midazolam (Table 3) . Electrolyte concentrations and venous blood gas analytes were affected by midazolam sedation although hematological values (PCV, Hgb, Hct) and pH were not (Tables 3-5 ). The midazolam-treated group had lower pO 2 and sO 2 while pCO 2 , TCO 2 , and HCO 3 were higher in birds receiving midazolam. Modeling of multiple variables (species, age, sex, and midazolam administration) found that some variability occurred based on species for all analytes (Table 5 ). However, blood gases and acid-base analytes appeared least affected by species (,27%). Age affected BE and HCO 3 while the effect of sex was limited to glucose, Hct, and Hgb. Most BUN values were below the limit of detection (2 mg/dL) for the analyzer (n=95); reported BUN values (n=12) were nonparametrically distributed (Shapiro-Wilk P,0.0001). Detection of BUN was 
Discussion sedation
Based on adequate sedation for most birds in this study and the death of only a single bird, midazolam appears safe and efficacious with a wide margin of safety for short-term field sedation in Passeriformes. Intranasal administration was chosen based on a previous study that found that this route was easy and offered high bioavailability, rapid onset of action, reduced pain compared to intramuscular administration, and reduced likelihood of neuromuscular damage in these very small species. 15 In addition, intranasal administration requires minimal training or equipment and is rapid and inexpensive. 27 However, full recovery and release of birds was not a goal of this study. Further study of midazolam reversal and monitoring prior to release as well as long term effects of this sedative drug on free-living avian species are recommended. This study was similar to a previous trial which found an increased risk of regurgitation with use of this drug, as this side effect was restricted to treated birds. 27 Body temperature, respiratory rate, and duration of recumbency were not assessed in this study, based on the difficulty of these assessments in field conditions and on small free-flighted subjects, but are recommended for future assessments of midazolam in birds. The dose range chosen was similar to those previously administered intranasally in other small, captive bird species such as budgerigars, finches, and canaries. 14, 17, 28 As expected, sedation increased based on increasing doses of midazolam. However, our calculated dose range extended to above that previously reported without causing apparent immediate harm in birds given higher doses, and many birds (n=14) were unacceptably sedated using doses at or above the previously recommended ranges. 12, 14, 15, 18 Our study supports the concept that a wide therapeutic window exists in Passeriformes, as in other species, and that the standard lower dose used on larger birds may not provide sufficient sedation in some small birds. Similarly, in the short-term, a higher dose may be safe for sedation. However species effect on sedation level, if any, was not assessed or determined based on small sample sizes.
analytes In contrast to a single previous study of the effect of midazolam on biochemical values in birds, multiple biochemical values varied based on midazolam administration in this study. 11 Glucose concentrations were higher in samples obtained from birds administered midazolam than those that were not. A sex-related effect was also further confirmed in this study as found previously. 19 Mechanisms for the relative hyperglycemia in male birds and birds receiving midazolam are unclear. However, estrogens, other hormones, and sedation can affect glucose levels possibly to the significant, although nonclinically relevant, extent observed. 29 Reduced struggling of the sedated bird could have lessened peripheral glucose use and metabolism of glycogen stores, resulting in increased blood glucose concentrations.
Despite low sample size, decreased BUN concentration and decreased likelihood of detecting BUN in birds receiving midazolam based on linear modeling suggests that this analyte deserves further investigation as a health indicator of Passeriformes. In birds, BUN is not the primary product of nitrogen metabolism but BUN concentration may increase with dehydration. 8 However, clinical-study notes failed to reveal clinical signs of dehydration or hemoconcentration in those birds with detectable BUN.
Increased potassium in the group untreated with midazolam could be attributable to increased hemolysis, rhabdomyolysis, or other exertional trauma in the group not receiving sedation. 9, 11 Certainly, capture myopathy has been reported in multiple avian species; Passeriformes may also be susceptible. [30] [31] [32] Dietary intake was considered an unlikely cause of this difference based on species grouping and similar times of year of sampling. Hemolysis was not assessed in this study. Intracellular concentrations of potassium in the Passeriforme erythrocyte have not been evaluated and would be an important consideration for future studies. While a variety of diseases have been associated with increased potassium concentrations, all birds sampled appeared healthy based on physical examination at the time of sampling. The lower chloride in the group administered midazolam was statistically 
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Midazolam sedates Passeriformes significant but a relatively minor clinical change; no sodium change was associated with this finding. Regurgitation, egg production, and other fluid loss may have resulted based on centrally mediated muscular relaxation of midazolam in this group, resulting in lower sodium. In Passeriformes administered midazolam, one must account for expected changes in electrolyte concentrations if these analytes are under scrutiny to assess population or ecosystem health.
Lactate concentrations were lower in birds receiving midazolam, suggesting that increased exertion occurred in birds not receiving midazolam. Anxiolysis, sedation, hypnosis, or the centrally mediated muscle relaxant effects of midazolam likely mediated this result. The similar pH and anion gap of the treated and untreated groups suggests that neither midazolam nor handling without midazolam creates life-threatening uncompensated acid-base imbalance. Thus, while midazolam is safe, it is not necessary unless complicated capture or sampling is anticipated. 9, 11 Increased venous concentrations of HCO 3 in birds treated with midazolam provides further evidence of acid-base compensation. Hypoventilation in these birds likely resulted in increased relative CO 2 concentrations; bicarbonate is then increased to normalize pH; thus, a relative increase in base excess in the treated group likely occurred based on compensatory relative metabolic alkalosis. pCO 2 was higher, and sO 2 % and pO 2 were lower, in birds administered midazolam suggesting a state of a relative hypoventilation in birds receiving this drug. These analytes were among those least affected by species, age, or sex. Hypotension and respiratory depression are common side effects of this drug in humans and may have occurred in the Passeriformes studied. Decreased respiratory rate has been reported after administration of this drug to avian species. 15, 27 Future studies should evaluate respiratory rate, cardiac output, and perfusion; however, some of these parameters are challenging to evaluate in a field setting.
Regardless of midazolam administration, birds maintained a relatively basic blood pH; temperature correction did not result in clinically relevant change in this value (pH T41.3 =7.507). Temperature correction of blood gas analytes were consistent with birds having a higher venous pO 2 and pCO 2 than humans which is similar to findings in other avian arterial blood gases. 9, [33] [34] [35] [36] An attenuated increase in body temperature has been reported in parrots after administration of midazolam; thus, parameters subject to temperature correction might be expected to change less in birds given midazolam based on the moderated temperature in treated birds. 15 However, cloacal temperature was not measured in treated or untreated birds based on the lack of technical feasibility.
No differences were noted for the erythrocyte para meters (PCV, Hct, Hgb) of birds that did and did not receive midazolam. Linear mixed modeling further supported that sex but not age or midazolam administration affected Hct and Hgb. PCV agreed poorly with Hct, as previously published. 19 Values for Hct averaged 14.8% lower on the iSTAT-1 ® system than that provided via centrifugal determination of PCV. This difference is likely based on different analysis methods; the shape, size, and density of avian blood cells; and increased glucose concentrations and the lower total protein of avian blood. 24, 37 The iSTAT-1 system is not recommended as a sole determinant of Hgb or Hct in birds as results do not agree clinically with the gold standard PCV. Use of a single correction factor for all avian species appears inappropriate based on findings in this study and other previously published data. 19, 35, 38 The iSTAT-1 system calculates Hgb (g/dL) as hematocrit (% PCV) ×0. 34 . 24 This calculation, which differs from that validated for Passeriformes, and the erroneous PCV determination make it highly unlikely that Hgb determined by the iSTAT-1 is accurate. We report results here only for completeness and recommend that future studies address the validity of this unit for determination of Hgb in birds.
Conclusion
Midazolam is efficacious and has a broad therapeutic safety margin for short-term sedation of free-living Passeriformes. However, the recovery period requires more study before we can recommend this sedative for field use in birds destined for release. Hematological variables (Hct, PCV, Hgb) were minimally affected by administration of midazolam. However, multiple blood gas parameters, electrolyte concentrations, and biochemical blood analytes were affected by administration of midazolam and should be taken into consideration if used to assess avian population health. Changes in glucose, potassium, and lactate concentrations support the hypothesis that midazolam lessens the stress of free-living birds undergoing capture. However, blood gas values suggest that birds administered midazolam suffer relative hypoventilation. Further assessment of midazolam for field use, as well as the companion reversal drug flumazenil to facilitate assessment of Passeriforme population and therefore ecosystem health, is recommended. 
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